These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16125198)

  • 1. Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif.
    Messerschmidt A; Macieira S; Velarde M; Bädeker M; Benda C; Jestel A; Brandstetter H; Neuefeind T; Blaesse M
    J Mol Biol; 2005 Sep; 352(4):918-31. PubMed ID: 16125198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic domain crystal structure of protein kinase C-theta (PKCtheta).
    Xu ZB; Chaudhary D; Olland S; Wolfrom S; Czerwinski R; Malakian K; Lin L; Stahl ML; Joseph-McCarthy D; Benander C; Fitz L; Greco R; Somers WS; Mosyak L
    J Biol Chem; 2004 Nov; 279(48):50401-9. PubMed ID: 15364937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of the PKC-iota kinase domain in its ATP-bound and apo forms reveal defined structures of residues 533-551 in the C-terminal tail and their roles in ATP binding.
    Takimura T; Kamata K; Fukasawa K; Ohsawa H; Komatani H; Yoshizumi T; Takahashi I; Kotani H; Iwasawa Y
    Acta Crystallogr D Biol Crystallogr; 2010 May; 66(Pt 5):577-83. PubMed ID: 20445233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor.
    Grodsky N; Li Y; Bouzida D; Love R; Jensen J; Nodes B; Nonomiya J; Grant S
    Biochemistry; 2006 Nov; 45(47):13970-81. PubMed ID: 17115692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique structural and functional properties of the ATP-binding domain of atypical protein kinase C-iota.
    Spitaler M; Villunger A; Grunicke H; Uberall F
    J Biol Chem; 2000 Oct; 275(43):33289-96. PubMed ID: 10906326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate recognition mechanism of atypical protein kinase Cs revealed by the structure of PKCι in complex with a substrate peptide from Par-3.
    Wang C; Shang Y; Yu J; Zhang M
    Structure; 2012 May; 20(5):791-801. PubMed ID: 22579248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the C2 domain from novel protein kinase Cepsilon. A membrane binding model for Ca(2+)-independent C2 domains.
    Ochoa WF; Garcia-Garcia J; Fita I; Corbalan-Garcia S; Verdaguer N; Gomez-Fernandez JC
    J Mol Biol; 2001 Aug; 311(4):837-49. PubMed ID: 11518534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of the human full-length protein kinase Ciota.
    Macek B; Benda C; Jestel A; Maskos K; Mann M; Messerschmidt A
    J Proteome Res; 2008 Jul; 7(7):2928-35. PubMed ID: 18489133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of atypical protein kinase C PB1 domain and its mode of interaction with ZIP/p62 and MEK5.
    Hirano Y; Yoshinaga S; Ogura K; Yokochi M; Noda Y; Sumimoto H; Inagaki F
    J Biol Chem; 2004 Jul; 279(30):31883-90. PubMed ID: 15143057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C isozymes and their selectivity towards ruboxistaurin.
    Tang S; Xiao V; Wei L; Whiteside CI; Kotra LP
    Proteins; 2008 Jul; 72(1):447-60. PubMed ID: 18214957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes.
    Kjær S; Linch M; Purkiss A; Kostelecky B; Knowles PP; Rosse C; Riou P; Soudy C; Kaye S; Patel B; Soriano E; Murray-Rust J; Barton C; Dillon C; Roffey J; Parker PJ; McDonald NQ
    Biochem J; 2013 Apr; 451(2):329-42. PubMed ID: 23418854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
    Fields AP; Frederick LA; Regala RP
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of the protein kinase C-theta activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factor-kappaB induction.
    Liu Y; Graham C; Li A; Fisher RJ; Shaw S
    Biochem J; 2002 Jan; 361(Pt 2):255-65. PubMed ID: 11772397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric regulation of PKCθ: understanding multistep phosphorylation and priming by ligands in AGC kinases.
    Seco J; Ferrer-Costa C; Campanera JM; Soliva R; Barril X
    Proteins; 2012 Jan; 80(1):269-80. PubMed ID: 22072623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of protein kinase C theta activation loop autophosphorylation and the kinase domain catalytic mechanism.
    Czerwinski R; Aulabaugh A; Greco RM; Olland S; Malakian K; Wolfrom S; Lin L; Kriz R; Stahl M; Huang Y; Liu L; Chaudhary D
    Biochemistry; 2005 Jul; 44(28):9563-73. PubMed ID: 16008341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the C2 domain from protein kinase C-delta.
    Pappa H; Murray-Rust J; Dekker LV; Parker PJ; McDonald NQ
    Structure; 1998 Jul; 6(7):885-94. PubMed ID: 9687370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
    Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
    Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta.
    Ranganathan S; Wang Y; Kern FG; Qu Z; Li R
    Proteins; 2007 May; 67(3):709-19. PubMed ID: 17335005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
    Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
    J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit.
    Akamine P; Madhusudan ; Brunton LL; Ou HD; Canaves JM; Xuong NH; Taylor SS
    Biochemistry; 2004 Jan; 43(1):85-96. PubMed ID: 14705934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.